Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
Introduction: Systematic review of real-world studies about repeated dexamethasone intravitreal implant (DEXi) 0.7 mg in diabetic macular edema management, in order to identify the effective window of time occurring between injections, the critical evaluation of efficacy of the treatment, and the re...
Saved in:
Main Authors: | Claudio Bucolo (Author), Lucia Gozzo (Author), Laura Longo (Author), Silvana Mansueto (Author), Daniela Cristina Vitale (Author), Filippo Drago (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
by: Stéphanie Baillif, et al.
Published: (2022) -
Pharmacoeconomic analysis of dexamethasone intravitreal implant for the treatment of diabetic macular edema in Russia
by: A. S. Kolbin, et al.
Published: (2018) -
Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
by: Dang Y, et al.
Published: (2014) -
Usefulness of Intravitreal dexamethasone implant in treatment of persistent cystoid macular edema due to Irvine-Gass syndrome
by: Mya Thida Ohn, et al.
Published: (2019) -
Widening use of dexamethasone implant for the treatment of macular edema
by: Bonfiglio V, et al.
Published: (2017)